What's new

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 11, Status: Authorised

May 23, 2025 - 18:55
 0
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

Artificial Intelligence Flags Interval Breast Cancers Visible at Screening

Next Article

Human medicines European public assessment report (EPAR): Retsevmo, selpercatini...

Related Posts

PSUSA/00002643/202408

PSUSA/00002643/202408

May 12, 2025  0

NovoRapid PumpCart (insulin aspart)

NovoRapid PumpCart (insulin aspart)

May 12, 2025  0

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0